The objective of this double-blinded crossover study was to examine the effects of marine oil supplementation with high-dose eicosapentaenoic acid (EPA) on canine pruritic skin disease. Sixteen dogs that completed this study had clinical signs related to idiopathic pruritus, confirmed atopy and/or flea allergy. Each dog was randomly placed on one omega-3 fatty acid capsule (MVP: Meridian Veterinary Products, St. Augustine, FL, U.S.A.) which contained 1 ml of marine oil (180 mg EPA and 120 mg DHA) or one capsule containing 1 ml of corn oil (570 mg linoleic acid and 50 mg gamma linolenic acid) per 4.55 kg of body weight q 24 h for 6 weeks. After a 3-week washout period in which no supplement was given, each subject was crossed over to the other supplement for an additional 6 weeks. Dogs receiving marine oil showed a significant improvement in pruritus (P < O.OOl), self-trauma (P < 0.05) and coat character (P <0.01) over time. When compared to the corn oil control over time, marine oil supplementation significantly improved pruritus (P < 0.02), alopecia (P < 0.05) and coat character (P < 0.001). This study demonstrates the effectiveness of high doses of marine oil as an alternative anti-inflammatory for canine pruritic skin disease.

No abstract

Decreased levels of total body zinc can lead to profound effects on both the immune and integumentary systems. Unfortunately, accurate measurements of total body zinc are difficult because the mineral is ubiquitous in the environment and many endogenous and exogenous factors can falsely elevate or depress measurements.In man, various dermatologic and non-dermatologic diseases have been associated with low serum zinc levels. The objective of this study was to analyse by atomic absorption and compare the serum zinc levels of healthy dogs, dogs with non-dermatologic diseases, dogs with allergic skin diseases and dogs with other dermatologic diseases. Using the Student-Newman-Keuls test, no significant differences in the mean serum zinc levels were demonstrated among any of the four groups (P > 0.05).

Abstract— The object of this study was to evaluate the effectiveness of Evening Primrose Oil (EPO) liquid (Efamol Vet; Guildford, U.K.) to decrease the signs of feline pruritic skin disease. Cats were accepted into the study if their dermatologic signs were related to probable flea allergy and/or atopy, their signs did not abate with increased flea control alone and they were not on any concurrent anti‐inflammatory drugs or supplements. They were initially placed on 4 weeks of intense flea control then randomly in a double‐blinded manner placed on either 8 weeks of EPO liquid or olive oil (control). Pruritus, erythema, self‐trauma, alopecia and overall dermatologic condition were monitored and scored at 4‐week intervals for the entire 12 weeks of study. The mean of each parameter for each group (EPO or olive oil) was compared to itself over time and to the other group using an analysis of variance with repeated measures. No significant difference (P≪ 0.05) was noted over time or between groups for any of the five parameters.

This pilot study was to determine if early oral flea exposure reduces the incidence of flea allergy dermatitis (FAD) in cats. Eighteen kittens, assigned to three groups, received no flea exposure, oral flea exposure or flea infestation for 12 weeks. Then all the kittens were exposed continually to fleas for 31 weeks. Sensitization was monitored using intradermal testing (IDT), in vitro measurement of anti-flea saliva immunoglobulin E (IgE) and development of FAD. There was no statistically significant difference between groups in IDT reactions, in vitro data or clinical scores. The development of FAD was not associated with the presence of anti-flea saliva IgE. However, the development of a delayed reaction to flea bite was associated with symptoms after flea exposure. Although not statistically significant, the FAD scores in the oral group were lower than in the controls. Further studies are required to determine the role of oral flea exposure in the development of FAD in cats.